Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Urology|February 22, 2011
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapyZe Lu, Teng-Kuang Yeh, Jie Wang, et al.
Pharmaceutical Research|May 23, 2006
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram developmentDanny Chen, Sae Heum Song, M Guillaume Wientjes, et al.
European Journal of Medicinal Chemistry|July 12, 2023
A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effectsYing-Ting Hsu, Shen-Ren Chen, Yung-Chiao Chang, et al.
Organic & Biomolecular Chemistry|December 24, 2015
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Organic & Biomolecular Chemistry|June 16, 2018
Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Chembiochem : a European Journal of Chemical Biology|June 22, 2013
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressorsHsueh-Yun Lee, Chia-Ron Yang, Mei-Jung Lai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2007
Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomesHsien-Tsung Yao, Yu-Shan Wu, Yi-Wei Chang, et al.
European Journal of Medicinal Chemistry|October 28, 2020
Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell diseaseZheng-Sheng Lai, Teng-Kuang Yeh, Yu-Chi Chou, et al.
Pageof 13